• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

FDA Rare Disease Patient Advocacy Day Photos

Rare Disease Day Page Banner
 

 

Partcipants arrive at the FDA
Participants arrive at the Food and Drug Administration's Rare Disease Patient Advocacy Day, March 1, 2012. This event is used to engage and educate the rare disease community on regulatory processes related to rare diseases.

 

 

Dr. Margaret Hamburg, Commissioner of FDA
Dr. Margaret Hamburg, Commissioner of Food and Drugs, addresses the participants of the FDA Rare Disease Patient Advocacy Day, March 1, 2012.
 
 

 

Dr. Margaret Hamburg, Commissioner of Food and Drugs, addresses the participants of the FDA Dr. Margaret Hamburg, Commissioner of Food and Drugs, addresses the participants of the FDA Rare Disease Patient Advocacy Day, March 1, 2012.
 

 

Dr. Stephen Spielberg, Deputy Commissioner, Medical Products and Tobacco, delivers the keynote address at the FDA
Dr. Stephen Spielberg, Deputy Commissioner, Medical Products and Tobacco, delivers the keynote address as part of the FDA's Rare Disease Patient Advocacy Day, March 1, 2012.

 

 

Sharon Terry, President and CEO of the Genetic Alliance, leads the days second panel discussion. 

Sharon Terry, President and CEO of the Genetic Alliance, leads the days second panel discussion where participants can present questions to panel members as part of the FDA's Rare Disease Patient Advocacy Day, March 1, 2012.

 

Emily Thakur, Center for Drug Evalation and Research (CDER), discusses CDER

 Emily Thakur, Center for Drug Evaluation and Research (CDER), discusses CDER's Drug Shortage Program as part of the FDA's Rare Disease Patient Advocacy Day, March 1, 2012.